Rani Therapeutics
RANI
RANI
36 hedge funds and large institutions have $15.5M invested in Rani Therapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $17.6M → $15.5M (-$2.15M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
81% less call options, than puts
Call options by funds: $5K | Put options by funds: $26K
Holders
36
Holding in Top 10
1
Calls
$5K
Puts
$26K
Top Buyers
| 1 | +$365K | |
| 2 | +$173K | |
| 3 | +$128K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$103K |
| 5 |
HF
HRT Financial
New York
|
+$93K |
Top Sellers
| 1 | -$318K | |
| 2 | -$198K | |
| 3 | -$106K | |
| 4 |
CH
Canton Hathaway
Providence,
Rhode Island
|
-$86K |
| 5 |
Jane Street
New York
|
-$76.3K |